Cataract blindness in the developing world: is there a solution?

Area of Science:

• Ophthalmology
• Global Health
• Surgical Innovation

Background:

• Cataracts are the primary cause of global blindness, disproportionately affecting developing countries.
• Millions of new cataract blindness cases emerge annually, overwhelming existing treatment capacities.
• Current surgical interventions in developing regions are often too costly or yield suboptimal outcomes, failing to address the escalating backlog.

Purpose of the Study:

• To evaluate the efficacy of a combined intracapsular cataract extraction with anterior chamber intraocular lens implantation (ICCE AC-IOL) as a cost-effective solution.
• To explore an alternative surgical approach for cataract treatment in resource-limited settings.
• To identify methods for reducing the significant backlog of untreated cataracts in developing nations.

Main Methods:

• Review of existing cataract surgery techniques used in developing countries.
• Analysis of the potential benefits of combining intracapsular cataract extraction (ICCE) with anterior chamber intraocular lens (AC-IOL) implantation.
• Comparison of ICCE AC-IOL with current standard procedures like extra capsular cataract extraction (ECCE) with posterior chamber intraocular lens (PC-IOL).

Main Results:

• Extra capsular cataract extraction (ECCE) with posterior chamber intraocular lens (PC-IOL) is considered a preferred but not universally accessible method.
• Intracapsular cataract extraction (ICCE) is currently the most common method in rural developing areas.
• Combining ICCE with AC-IOL implantation presents a potentially cost-effective and efficacious approach to cataract surgery.

Conclusions:

• The combination of ICCE with AC-IOL implantation may offer a viable strategy to reduce the substantial backlog of cataract blindness in developing countries.
• This surgical approach could enhance sight rehabilitation efforts by providing an affordable and effective treatment option.
• Further research and implementation are needed to assess the full impact of ICCE AC-IOL on global cataract burden.